Practice tip:
About 1% of sporadic uterine leiomyomas are fumarate hydratase deficient. But HLRCC syndrome is rare. So it is challenging to decide which people with fumarate hydratase deficient leiomyomas should be referred for genetic counselling/testing.
If multiple FH deficient leiomyomas -> refer
If FH deficient leiomyoma under 40 years ->refer
If a solitary FH deficient leiomyoma -> look in the adjacent myometrium. In my experience, scattered 2SC positive clusters of morphologically non-neoplastic cells are only ever seen in syndromic disease.
This is 2SC immunohistochemistry where I am trying to illustrate this finding. Anyone else seen this?
The State Funeral for Profesor Richard Scolyer will be held on Monday 13 July 2026 at the Sydney Opera House.
The details are available at:
State Memorial Service for Professor Richard Scolyer AO pmc.gov.au/scolyer
Our latest article in @AJSPjournal is now officially printed. We examine the proposed changes for the AJCC 9th edition staging of colorectal carcinoma. The proposals reset the relative balance between depth of invasion (T-stage) and nodal metastasis (N-stage); and more appropriatley recognizes the adverse effects of tumour deposits (carcinoma in soft tissue not associated with nodes)
Availalble for free download at:
journals.lww.com/ajsp/fullte…
Key points:
The good:
1. The new proposal ends the stage 3A paradox (that under the old eighth edition stage 3A does much better than stage 2)
2. The new proposal appropriately recognizes tumour deposits as an additional adverse finding (not as equivalent to node mets). That is, it recognizes that patients with tumour deposits and node mets do worse than those with one or the other only.
Room for improvement?
3. However our data shows that low T-stage (T1 and T2) patients with lymph node metastase do better than those without! Perhaps this should be considered in new stage groupings.
4. This results in the new proposed stage IIB being a heterogeneous group with the excellent prognosis T1 and T2 and intermediate prognosis T3 group
5. Proposed stage group 1 and 2A both have an excellent prognosis. Perhaps these should be renamed group 1A and group 1B to emphasize the similarities between these two groups of low T-stage disease (T1 and T2 respectively but node negative) rather than the differences.
Thoughts?
Ever year I put out this summary of the impact factors of the pathology journals that I most value reading. The new impact factors have just been released, and there are some interesting trends. Of course there is much more to journal selection than the impact factor . . . to me the main thing is targetting the audience that you most want to read your article. For example some articles are best read by national audiences, others by internatonal readership . . . some by subspeciality pathologists, others by general diagnostic surgical pathologists, still others by basic scientists interested in pathology.
I am deeply saddened by the passing of a great individual @ProfRAScolyer. Richard truly demonstrated the power of a single person who was passionate to influence so many.
A lot has been written about his research achievements and his advocacy in melanoma and brain cancer (which are truly phenomenal and globally recognized).
Beyond these achievements which are so well known and appreciated by the wider community, I want to emphasize that he was also a great advocate for high quality anatomical/surgical pathology. In his farewell letter he emphasized his pride in helping to start the world's largest melanoma tumour bank and his publications not just in melanoma but in melanoma pathology. He truly understood the role pathology plays in a patient's cancer journal and advocated at all levels for the specialty. He spent so much of his time teaching and promoting the discipline of surgical pathology; and he truly mentored so many.
As he wrote:
"A terminal cancer diagnosis does however provide clarity as to what truly matters. It shines a spotlight on the importance of relationships, on true friendship and on selflessness. Whilst cancer may not define us, our ability to empathise with and have compassion towards others does. That is true in all facets of life, and I am confident those traits will continue to guide Australians towards acceptance and support for all."
Also . . . he was also tremendous fun and entertaining in the social setting. This is from a party 25 years ago.
Proud to present our latest article - now available for free download @AJSPjournal
Please retweet and download the article.
Synopsis:
The AJCC ninth edition staging system for colon cancer is not yet current, but there are significant changes proposed. These changes aim to both get rid of the stage 3A paradox (under the eighth edition patients with Stage 3A actually disease do better than Stage 1 and 2) and also to better integrate discontinuous Tumour Deposits (TDs) into staging.
What are these proposals and do they work?
Free download:
journals.lww.com/ajsp/fullte…
















